CELADON PHARMACEUTICALS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.5 GBX | -2.50% |
|
-4.88% | -15.22% |
| 05-14 | Headlam warns of loss; EnSilica predicts revenue rise | AN |
| 05-14 | Celadon Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 81.36M | - | - | - | - | - | |
| 694B | ||||||
| 593B | ||||||
| 371B | ||||||
| 331B | ||||||
| 290B |
